Anthony Patron
Analyst, Mizuho Securities
Replay available
Pulse Biosciences, Inc (PLSE) Q2 2025 Earnings Call
Pulse Biosciences, Inc (NASDAQ: PLSE) Q2 2025 earnings conference call, held 2025-08-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Josh Jennings
Analyst, TD Cowan
John Skinner
Chief Financial Officer
Siraj Kalia
Analyst, Oppenheimer & Co.
Tripp Taylor
Vice President, Investor Relations
Paul LaViolette
Co-Chair of the Board and Chief Executive Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Pulse Biosciences, Inc.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.458 Thank you for standing by. Hello and welcome to the Pulse Biosciences 00:00:05.458 -- 00:00:09.142 second quarter 2025 earnings conference call. 00:00:09.142 -- 00:00:12.046 Please note that this call is being recorded. 00:00:12.046 -- 00:00:16.431 I would now like to hand the call over to Tripp Taylor. 00:00:16.431 -- 00:00:19.252 Sir, please go ahead. 00:00:22.779 -- 00:00:23.960 Thank you, operator. 00:00:23.960 -- 00:00:28.427 Before we begin, I would like to inform you that comments and responses to your questions 00:00:28.427 -- 00:00:33.475 during today's call reflect management's views as of today, August 12, 2025 00:00:33.475 -- 00:00:38.122 only, and will include forward-looking statements and opinion statements, including predictions, 00:00:38.122 -- 00:00:42.449 estimates, plans, expectations, and other similar information. 00:00:42.449 -- 00:00:47.116 Actual results may differ materially from those expressed or implied as a result of certain 00:00:47.116 -- 00:00:51.704 risks and uncertainties. These risks and uncertainties are more fully described in our 00:00:51.704 -- 00:00:56.532 press release issued earlier today and in our filings with the US Securities and Exchange 00:00:56.532 -- 00:00:57.934 Commission. 00:00:57.934 -- 00:01:02.480 Our SEC filings can be found on our website or the SEC's website. 00:01:02.480 -- 00:01:07.127 Investors are cautioned not to place undue reliance on forward-looking statements. 00:01:07.127 -- 00:01:12.075 We disclaim any obligation to update or revise these forward-looking statements. 00:01:12.075 -- 00:01:15.344 We will also discuss certain non-GAAP financial measures. 00:01:15.344 -- 00:01:20.009 Disclosures regarding these non-GAAP financial measures, including reconciliations ...